News

Filter

Current filters:

GentiumRegulation

Gentium withdraws US NDA for defibrotide

19-08-2011

Italian drug developer Gentium SpA (Nasdaq: GENT) saw its shares price plunge 29% to $6.22 on the Nasdaq…

Cardio-vasculardefibrotideGentiumNorth AmericaPharmaceuticalRegulationSigma Tau

Back to top